Brian Sherer
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 4
- Biochemical and Molecular Research 4
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Maria Uria-Nickelsen (4 shared papers)Ann E. Eakin (4 shared papers)Gregory S. Basarab (3 shared papers)Ruth Illingworth (3 shared papers)John I. Manchester (2 shared papers)Sheila I. Hauck (2 shared papers)Pamela Hill (2 shared papers)P. Ann Boriack‐Sjodin (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)ChemMedChem (2 papers)Journal of Medicinal Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Tetrahedron (1 paper)
- Partner nations
- United StatesItalySwitzerland
In The Last Decade
Brian Sherer
14 papers receiving 378 citations
Peers
Comparison fields: 5 of 62
- Toxicology 73
- Molecular Medicine 75
- Organic Chemistry 137
- Molecular Biology 241
- Pharmacology 41
Countries citing papers authored by Brian Sherer
This map shows the geographic impact of Brian Sherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Sherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Sherer more than expected).
Fields of papers citing papers by Brian Sherer
This network shows the impact of papers produced by Brian Sherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Sherer. The network helps show where Brian Sherer may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Sherer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 97 | |
| 2 | 2013 | 72 | |
| 3 | 2014 | 68 | |
| 4 | 2020 | 52 | |
| 5 | 2018 | 19 | |
| 6 | 2023 | 16 | |
| 7 | 2012 | 15 | |
| 8 | 2018 | 15 | |
| 9 | 2001 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 2018 | 4 | |
| 12 | 2018 | 4 | |
| 13 | 2020 | 4 | |
| 14 | 2021 | 1 | |
| 15 | 2011 | 0 |
About Brian Sherer
Brian Sherer is a scholar working on Molecular Biology, Genetics, Organic Chemistry, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 387 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer therapeutics and mechanisms (4 papers), Biochemical and Molecular Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Immune Response and Inflammation (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Toxicology (73 citations), Molecular Medicine (75 citations), Organic Chemistry (137 citations), Molecular Biology (241 citations) and Pharmacology (41 citations). Brian Sherer has collaborated with scholars based in United States, Italy and Switzerland. Frequent co-authors include Maria Uria-Nickelsen, Ann E. Eakin, Gregory S. Basarab, Ruth Illingworth, John I. Manchester, Sheila I. Hauck, Pamela Hill, P. Ann Boriack‐Sjodin, Kenneth G. Hull and Theresa Johnson. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ChemMedChem, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.